| Literature DB >> 33919381 |
Lourenço Ramos-Pinto1,2,3, Marina Machado1,2, Josep Calduch-Giner4, Jaume Pérez-Sánchez4, Jorge Dias3, Luís E C Conceição3, Tomé S Silva3, Benjamín Costas1,2.
Abstract
AAs have become interesting feed ingredients to be used in functional fish feeds as not only are they protein building blocks, but they also participate in several other key metabolic processes. In the present study, a comprehensive analysis of transcriptomics, hematology, and humoral immune parameters (plasma and skin mucus) were measured twice over the course of the feeding trial (four weeks). Plasma antiprotease activity increased in fish fed Thr compared to those fed the CTRL and Tau treatments, regardless of sampling time. The bactericidal activity in skin mucus decreased in fish fed Tau and His treatments compared to those fed the CTRL diet after two weeks. The membrane IgT (mIgT) was upregulated in fish fed Tau after four weeks, while C-type lectin domain family domain 10 member (clec10a) was downregulated in fish fed Thr after two weeks of feeding. By comparing the molecular signatures of head-kidney by means of a PLS-DA, it is possible to visualize that the main difference is between the two sampling points, regardless of diet. Altogether, these results suggest that dietary supplementation with these AAs at the tested levels causes mild immune-modulation effects in gilthead seabream, which should be further studied under disease challenge conditions.Entities:
Keywords: amino acids; blood leucocytes; immune-modulation; mucosal immunity
Year: 2021 PMID: 33919381 PMCID: PMC8143364 DOI: 10.3390/ani11051193
Source DB: PubMed Journal: Animals (Basel) ISSN: 2076-2615 Impact factor: 2.752
Ingredients of the experimental diets.
| Ingredients (% Feed Basis) | Experimental Diets | |||
|---|---|---|---|---|
| CTRL | HIS | TAU | THR | |
| Fishmeal LT70 (NORVIK) a | 12.00 | 12.00 | 12.00 | 12.00 |
| Poultry meal 65 b | 5.00 | 5.00 | 5.00 | 5.00 |
| Soy protein concentrate (Soycomil) c | 8.50 | 8.50 | 8.50 | 8.50 |
| Wheat gluten d | 7.37 | 7.37 | 7.37 | 7.37 |
| Corn gluten e | 8.00 | 8.00 | 8.00 | 8.00 |
| Soybean meal 48 f | 7.68 | 7.68 | 7.68 | 7.68 |
| Soybean meal 44 g | 15.00 | 15.00 | 15.00 | 15.00 |
| Rapeseed meal h | 5.00 | 5.00 | 5.00 | 5.00 |
| Wheat meal i | 14.30 | 14.30 | 14.30 | 14.30 |
| Sardine oil j | 4.65 | 4.65 | 4.65 | 4.65 |
| Rapeseed oil k | 10.85 | 10.85 | 10.85 | 10.85 |
| Vit & Min Premix INVIVO 1% l | 1.00 | 1.00 | 1.00 | 1.00 |
| Antioxidant m | 0.20 | 0.20 | 0.20 | 0.20 |
| Sodium propionate n | 0.10 | 0.10 | 0.10 | 0.10 |
| MCP o | 0.20 | 0.20 | 0.20 | 0.20 |
| DL-Methionine p | 0.15 | 0.15 | 0.15 | 0.15 |
| L-Threonine q | 0.75 | |||
| L-Histidine r | 0.40 | |||
| Taurine s | 0.50 | |||
|
| ||||
| Dry matter (% feed) | 94.6 | 94.3 | 94.2 | 94.3 |
| Crude protein (% dry weight) | 42.62 | 41.92 | 42.24 | 42.23 |
| Crude lipid (% dry weight) | 18.3 | 19.1 | 18 | 18.3 |
| Ash (% dry weight) | 6.4 | 6.1 | 6.3 | 6.1 |
| Gross Energy (kJ g−1 DM) | 21.83 | 21.75 | 21.37 | 22.00 |
a Fish meal LT70: 71.9%CP (crude protein), 6.8% CF (crude fat), Norvik Sopropêche, France b Poultry meal: 65%CP, 14.4% CF, SAVINOR UTS, Portugal c Soycomil P: 63% CP, 0.8% CF, ADM, The Netherlands d Wheat gluten: 80.4% CP; 5.6% CF, VITAL Roquette, France e Corn gluten meal: 61% CP, 6% CF, COPAM, Portugal. f Soybean meal 48: Solvent extracted dehulled soybean meal: 47% CP, 2.6% CF, CARGILL, Spain g Soybean meal 44: Solvent extracted dehulled soybean meal: 44% CP, 1.8% CF, CARGILL, Spain h Rapeseed meal: Defatted rapeseed meal: 37.7% CP, 2.3% CF, Premix Lda, Portugal i Wheat meal: 11.7% CP; 1.6% CF, Casa Lanchinha, Portugal j Sardine oil, 98.1% CF, Norvik Sopropêche, France k Rapeseed oil, 98.2% CF Henry Lamotte Oils GmbH, Germany l Vitamin and mineral premix: INVIVONSA Portugal SA, Portugal: Vitamins (IU or mg/kg diet): DL-alpha tocopherol acetate, 100 mg; sodium menadione bisulfate, 25 mg; retinyl acetate, 20,000 IU; DL-cholecalciferol, 2000 IU; thiamin, 30 mg; riboflavin, 30 mg; pyridoxine, 20 mg; cyanocobalamin, 0.1 mg; nicotinic acid, 200 mg; folic acid, 15 mg; ascorbic acid, 500 mg; inositol, 500 mg; biotin, 3 mg; calcium panthotenate, 100 mg; choline chloride, 1000 mg, betaine, 500 mg. Minerals (g or mg/kg diet): copper sulphate, 9 mg; ferric sulphate, 6 mg; potassium iodide, 0.5 mg; manganese oxide, 9.6 mg; sodium selenite, 0.01 mg; zinc sulphate, 7.5 mg; sodium chloride, 400 mg; excipient wheat gluten. m Antioxidant: VERDILOX, Kemin Europe NV, Belgium n Sodium propionate: Disproquímica, Portugal o Monocalcium phosphate: Premix Lda, Portugal p DL-Methionine: DL-METHIONINE FOR AQUACULTURE 99%, EVONIK Nutrition & Care GmbH, Germany q L-Threonine: ThreAMINO 98.5%, Evonik Nutrition & Care GmbH, Germany r L-Hisdidine: L-Histidine 98%, Ajinomoto Eurolysine SAS, France s L-Taurine: L-Taurine 98%, ORFFA, The Netherlands. control (CTRL), histidine (His), taurine (Tau), and threonine (Thr).
Amino acid (AA) composition (g AA 100 g−1 CP) of the experimental diets.
| AA | Experimental Diets | |||
|---|---|---|---|---|
| CTRL | HIS | TAU | THR | |
| Arginine | 7.6 | 6.1 | 6.3 | 5.7 |
| Histidine | 2.1 | 3.4 | 2.6 | 2.4 |
| Lysine | 5.3 | 6.3 | 6.7 | 6.2 |
| Threonine | 3.8 | 3.5 | 3.6 | 4.3 |
| Isoleucine | 4.5 | 4.2 | 4.3 | 4.1 |
| Leucine | 8.4 | 7.2 | 7.1 | 6.9 |
| Valine | 4.8 | 4.9 | 5.0 | 4.7 |
| Methionine | 2.3 | 2.5 | 2.9 | 2.2 |
| Phenylalanine | 5.3 | 4.0 | 4.0 | 3.8 |
| Cystine | 0.6 | 1.3 | 1.3 | 1.3 |
| Tyrosine | 4.0 | 3.4 | 3.5 | 3.1 |
| Aspartic acid + Asparagine | 7.4 | 9.6 | 10.1 | 9.5 |
| Glutamic acid + Glutamine | 19.0 | 21.8 | 19.0 | 21.9 |
| Alanine | 4.8 | 4.8 | 5.0 | 4.6 |
| Glycine | 5.1 | 4.4 | 4.9 | 4.2 |
| Proline | 6.7 | 6.6 | 6.5 | 6.4 |
| Serine | 4.5 | 4.4 | 4.5 | 4.4 |
| Taurine | 0.3 | 0.3 | 1.0 | 0.2 |
Tryptophan was not analyzed. control (CTRL), histidine (His), taurine (Tau), and threonine (Thr).
Genes included in head kidney pathway-focused PCR array.
| Gene Name/Category | Symbol | Gene Name/Category | Symbol |
|---|---|---|---|
|
|
| ||
| Interleukin-1 beta |
| Cluster of differentiation 3 zeta chain |
|
| Interleukin-6 |
| CD4-full |
|
| Interleukin-7 |
| Cluster of differentiation 8 alpha |
|
| Interleukin-8 |
| Cluster of differentiation 8 beta |
|
| Interleukin-10 |
| Zeta-chain-associated protein kinase 70 |
|
| Interleukin 12 subunit beta |
| ||
| Interleukin-15 |
| ||
| Interleukin-34 |
|
| |
| Tumor necrosis factor-alpha |
| Toll-like receptor 2 |
|
| Toll-like receptor 5 |
| ||
|
| Toll-like receptor 9 |
| |
| Macrophage colony-stimulating factor 1 receptor 1 |
| Macrophage mannose receptor 1 |
|
| C-C chemokine receptor type 3 |
| ||
| C-C chemokine CK8/C-C motif chemokine 20 |
|
| |
| Hepcidin |
| ||
|
| |||
| Immunoglobulin M |
|
| |
| Immunoglobulin M membrane-bound form |
| Complement factor 3 |
|
| Immunoglobulin T |
| ||
| Immunoglobulin T membrane-bound form |
|
| |
| C-type lectin domain family 10 member A |
| ||
|
| |||
| Caspase 3 |
| ||
Colors in background is to distinguish the different pathways.
Body weight (BW, g fish−1) and relative growth rate (RGR, % day−1) of gilthead seabream fed the experimental diets for two and four weeks.
|
|
|
|
|
| ||||||
|
|
|
|
|
|
|
|
| |||
| FBW (g fish-1) | 11.07 ± 0.23 | 14.49 ± 2.10 | 10.89 ± 0.30 | 14.04 ± 1.49 | 11.08 ± 0.33 | 13.89 ± 1.08 | 11.13 ± 0.49 | 13.70 ± 0.10 | ||
| RGR (RGR, % day-1) | 1.63 ± 0.28 | 1.76 ± 0.50 | 1.65 ± 0.51 | 1.73 ± 0.35 | 1.54 ± 0.18 | 1.58 ± 0.32 | 1.84 ± 0.48 | 1.67 ± 0.09 | ||
|
| ||||||||||
|
|
|
|
|
|
| |||||
|
|
|
|
|
|
| |||||
| BW | 0.925 | <0.001 | 0.893 | A | B | - | - | - | - | |
| RGR | 0.814 | 0.911 | 0.898 | - | - | - | - | - | - | |
Values are presented as means ± SD (n = 12 and n = 3 for feed intake). p-values from two-way ANOVA (p ≤ 0.05). Tukey’s post-hoc test was used to identify differences in the experimental treatments. A,B: Different capital letters indicate differences between diets regardless of time or difference between times regardless of diets. Initial body weight was 8.77 ± 0.13 g.control (CTRL), histidine (His), taurine (Tau), and threonine (Thr), final body weight (FBW).
Hemoglobin, red blood cells (RBC), and white blood cells (WBC) of gilthead seabream fed dietary treatments during two and four weeks.
|
|
|
|
|
|
| |||||||
|
|
|
|
|
|
|
|
|
| ||||
| Hemoglobin | (g dL−1) | 0.60 ± 0.10 | 0.60 ± 0.06 | 0.60 ± 0.05 | 0.65 ± 0.09 | 0.65 ± 0.04 | 0.57 ± 0.03 | 0.56 ± 0.05 | 0.54 ± 0.06 | 0.67 ± 0.10 | ||
| WBC | (×104 µL) | 4.66 ± 0.33 b | 4.53 ± 0.60 b | 6.21 ± 0.36 | 3.34 ± 0.20 a | 7.11 ± 0.56 | 4.85 ± 0.28 b | 7.00 ± 0.40 | 4.94 ± 0.47 b | 5.94 ± 0.56 | ||
| RBC | (×106 µL) | 1.55 ± 0.15 | 1.14 ± 0.09 | 1.44 ± 0.10 | 1.28 ± 0.11 | 1.58 ± 0.04 | 1.00 ± 0.06 | 1.42 ± 0.09 | 1.24 ± 0.11 | 1.66 ± 0.12 | ||
| Absolute peripheral blood leucocytes | ||||||||||||
| Thrombocytes | (×104 µL) | 3.31 ± 0.23 | 3.46 ± 0.57 | 4.54 ± 0.26 | 2.46 ± 0.18 | 4.77 ± 0.36 | 3.62 ± 0.27 | 5.19 ± 0.40 | 3.56 ± 0.35 | 4.60 ± 0.47 | ||
| Lymphocytes | (×104 µL) | 1.21 ± 0.23 ab | 0.93 ± 0.14 | 1.37 ± 0.18 ab | 0.70 ± 0.34 * | 1.95 ± 0.49 b# | 0.98 ± 0.46 | 1.49 ± 0.48 ab | 1.22 ± 0.49 | 1.11 ± 0.43 a | ||
| Monocytes | (×104 µL) | 0.02 ± 0.01 | 0.02 ± 0.01 | 0.06 ± 0.02 | 0.02 ± 0.01 | 0.06 ± 0.02 | 0.04 ± 0.01 | 0.08 ± 0.02 | 0.07 ± 0.02 | 0.06 ± 0.02 | ||
| Neutrophils | (×104 µL) | 0.13 ± 0.03 | 0.07 ± 0.02 | 0.22 ± 0.04 | 0.08 ± 0.03 | 0.18 ± 0.02 | 0.18 ± 0.03 | 0.25 ± 0.02 | 0.09 ± 0.01 | 0.15 ± 0.04 | ||
|
| ||||||||||||
|
|
|
|
|
|
| |||||||
|
|
|
|
|
|
|
| ||||||
| Hemoglobin | (g dl −1) | 0.633 | 0.538 | 0.699 | - | - | - | - | - | - | - | |
| WBC | (×104 µL) | 0.406 | <0.001 | 0.017 | A | A | B | - | - | - | - | |
| RBC | (×106 µL) | 0.286 | <0.001 | 0.898 | B | A | B | - | - | - | - | |
|
| ||||||||||||
| Thrombocytes | (×104 µL) | 0.214 | <0.001 | 0.298 | A | A | B | - | - | - | - | |
| Lymphocytes | (×104 µL) | 0.74 | <0.001 | 0.003 | AB | A | B | - | - | - | - | |
| Monocytes | (×104 µL) | 0.071 | 0.003 | 0.116 | AB | A | B | - | - | - | - | |
| Neutrophils | (×104 µL) | 0.006 | <0.001 | 0.287 | A | A | B | AB | AB | B | A | |
Values are presented as means ± SE (n = 9). p-values from two-way ANOVA (p ≤ 0.05). Tukey’s post-hoc test was used to identify differences in the experimental treatments. a, b: Different lowercase letters stand for significant differences between dietary treatments for the same time. A, B: Different capital letters indicate differences between diets regardless of time or difference between times regardless of diets. Different symbols indicate difference between times for the same dietary treatment. control (CTRL), histidine (His), taurine (Tau), and threonine (Thr).
Plasma and mucus humoral parameters of gilthead seabream fed dietary treatments during two and four weeks.
|
|
|
|
|
|
| ||||||||
|
|
|
|
|
|
|
|
|
| |||||
| Plasma | |||||||||||||
| Bactericidal activity | (%) | 28.57 ± 7.31 | 43.75 ± 2.14 | 47.56 ± 3.01 | 37.65 ± 2.56 | 48.25 ± 2.76 | 38.47 ± 2.20 | 39.92 ± 3.30 | 42.39 ± 3.40 | 43.54 ± 2.90 | |||
| Antiprotease | (%) |
| 92.02 ± 0.99 | 92.69 ± 1.43 | 94.60 ± 0.59 | 95.45 ± 1.01 | 90.06 ± 0.85 | 94.56 ± 0.59 | 91.71 ± 1.04 | 95.97 ± 0.50 | |||
| Peroxidase | (U/mL) |
| 6.29 ± 0.71 | 7.07 ± 0.71 | 6.60 ± 0.79 | 7.18 ± 0.55 | 6.34 ± 0.64 | 6.44 ± 0.43 | 6.95 ± 0.43 | 7.94 ± 1.00 | |||
| IgM | (abs) | 0.80 ± 0.11 | 0.85 ± 0.02 | 0.72 ± 0.05 | 0.77 ± 0.04 | 0.68 ± 0.06 | 0.66 ± 0.04 | 0.74 ± 0.04 | 0.81 ± 0.05 | 0.66 ± 0.05 | |||
| Mucus | |||||||||||||
| Bactericidal activity | (%) | 60.53 ± 1.02 a | 66.41 ± 0.63 *b | 55.83 ± 1.76 # | 64.57 ± 0.89 ab | 59.11 ± 1.59 | 60.80 ± 1.34 a | 59.08 ± 1.19 | 59.40 ± 1.26 a | 57.69 ± 1.49 | |||
| Antiprotease | (%) | 29.45 ± 2.37 | 25.52 ± 2.70 | 26.99 ± 1.33 | 28.10 ± 1.97 | 26.88 ± 1.31 | 28.36 ± 2.10 | 28.69 ± 2.49 | 27.52 ± 0.90 | 30.62 ± 2.6 | |||
| Peroxidase activity | (U/mg) | 0.66 ± 0.06 | 0.73 ± 0.09 | 0.69 ± 0.09 | 0.89 ± 0.10 | 0.78 ± 0.11 | 1.00 ± 0.12 | 0.71 ± 0.08 | 0.81 ± 0.11 | 0.78 ± 0.41 | |||
|
| |||||||||||||
|
|
|
|
|
|
| ||||||||
|
|
|
|
|
|
|
| |||||||
| Plasma | |||||||||||||
| Bactericidal activity | (%) | 0.151 | 0.037 | 0.343 | A | AB | B | - | - | - | - | ||
| Antiprotease | (%) | 0.013 | <0.001 | 0.059 | - | A | B | A | B | A | AB | ||
| Peroxidase | (U/mL) | 0.471 | 0.208 | 0.926 | - | - | - | - | - | - | - | ||
| IgM | (abs) | 0.302 | 0.023 | 0.045 | B | B | A | - | - | - | - | ||
| Mucus | |||||||||||||
| Bactericidal activity | (%) | 0.053 | <0.001 | 0.001 | AB | B | A | - | - | - | - | ||
| Antiprotease | (%) | 0.012 | 0.149 | 0.102 | - | - | - | A | AB | AB | B | ||
| Peroxidase activity | (U/mg) | 0.452 | 0.1 | 0.541 | - | - | - | - | - | - | - | ||
Values are presented as means ± SE (n = 12). p-values from two-way ANOVA (p ≤ 0.05). Tukey’s post-hoc test was used to identify differences in the experimental treatments. a, b: Different lowercase letters stand for significant differences between dietary treatments for the same time. A, B: Different capital letters indicate differences between diets regardless of time or difference between times regardless of diets. Different symbols indicate difference between times for the same dietary treatment. ⨂ There was not enough sample to perform this analysis due to fish size constraints. control (CTRL), histidine (His), taurine (Tau), and threonine (Thr).
Figure 1Relative expression of Immunoglobulin T membrane-bound form (IgT-m, (A) C-type lectin domain family 10 member A (clec10a, (B) genes in the head-kidney of gilthead seabream at time Ø and fed the dietary treatments during two and four weeks. Values are presented as means ± SE (n = 9). p-values from two-way ANOVA (p ≤ 0.05). Tukey’s post-hoc test was used to identify differences in the experimental treatments. a,b: Different lowercase letters stand for significant differences among dietary treatments for the same sampling time. treatment.control (CTRL), histidine (His), taurine (Tau), and threonine (Thr)